Myeloprotective effect of short term prechemotherapy recombinant granulocyte-macrophage colony stimulating factor.
Akyüz
Canan
C
Department of Pediatric Oncology, Hacettepe University, Institute of Oncology, Ankara, Turkey.
Cağlar
Kudret
K
Varan
Ali
A
Köseoğlu
Vedat
V
Canpinar
Hande
H
Kutluk
Tezer
T
Büyükpamukçu
Münevver
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D004334:Drug Administration Schedule; D005260:Female; D005434:Flow Cytometry; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage*; D006801:Humans; D007279:Injections, Subcutaneous; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D009503:Neutropenia / Q000139:chemically induced / Q000517:prevention & control*; D011292:Premedication; D011994:Recombinant Proteins; D016896:Treatment Outcome
D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor